- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03065868
Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp
Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp (Randomized Controlled Study)
Evaluation of the effect of H. pylori eradication on regression of H. pylori-related gastric polyp (Ranomized controlled trial)
- Study design: open labeled RCT
- Study group H. pylori eradication group (N=17), non-eradication group (N=15)
Treatment plan
Baseline EGD
: 0.3-1cm sized polyp - bx & CLO test (antrum & body)
==> if H. pylori positive and eligible patients, randomization
- Triple therapy
- UBT (4week after eradication)
- Follow-up EGD: gross finding, CLO test
Evaluation of polyp regression
- disappear
- regression over 50% (size, number)
- no change or increase (size, number)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
(A) Study population
- inclusion HP-realetd polyp polyp size with 0.3cm-1cm 20 yr - 70yr
- exclusion peptic ulcer, healing stage or acute stage recent use of PPI within 4weeks Liver cirrhosis, renal insufficiency, other serious chronic or acute disease current infection of other bacteria, virus, or fungus cancer, psychologic disease heavy drinker drug abuser pregnant women, Penicillin allergy, digoxin, antifungal, wafarin previosu H. pylori eradication enroll gastric polyp with bleeding or malignant transformation tiny polyp less than 3mm.
(B) Study method
- Study design: open labeled RCT
- Study group H. pylori eradication group (N=17), non-eradication group (N=15)
Treatment plan
- Baseline EGD: 0.3-1cm sized polyp - bx & CLO test (antrum & body) ==> if H. pylori positive and eligible patients, randomization
- Triple therapy
- UBT (4week after eradication) if eradication failure in triple therapy, 2nd line treatment (metroniazole based quadraple therpay) and the UBT (4week after eradication)
- Follow-up EGD (3-9M): gross finding, CLO test
Evaluation of polyp regression
- disappear
- regression over 50% (size, number)
- no change or increase (size, number)
Statistical analysis
- Chi-square test to compare polyp regression between treatment & control group.
- t-test to compare continuous variables between treatment & control group.
- Paired T-test to compare the size between baseline and follow-up EGD.
- Regression analysis: univariate & multivariate analysis.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Daegu, Korea, Republic of, 41404
- Su Youn Nam
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gastric polyp with current infection of H. pylori
- Gastric polyp size with 3mm-10mm
- Age of 20 yr - 70yr
Exclusion Criteria:
- Gastric ulcer ir duodenal ulcer (healing stage or acute stage)
- Use of PPI within 4weeks
- Liver cirrhosis, renal insufficiency, other serious chronic or acute disease
- Current infection of other bacteria, virus, or fungus
- Any cancer, psychologic disease
- Heavy drinker
- Drug abuser
- Pregnant women
- Penicillin allergy
- Use of digoxin, antifungal, wafarin
- Previous H. pylori eradication
- Gastric polyp with bleeding or malignant transformation
- Tiny polyp less than 3mm.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: eradictaion
H. pylori eradication group
|
H. pylori eradication (Triple Therapy) as first line treatment if eradication failure, quadruple therpy will be provided as 2nd line treatment
Other Names:
|
No Intervention: non-eradication
H. pylori non-eradication group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare regression rate of gastric polyps between H. pylori eradication and non-eradication groups. Regression of gastric polyp: one of below 1) Disappearance of gastric polyp 2) Reduction of polyp size over 50%
Time Frame: up to 24months
|
Evaluation of the effect of H. pylori eradication on the regression of H. pylori associated gastric polyp Study group
Definition of gastric polyp change:
|
up to 24months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Su Youn Y Nam, MD, PhD, Kyungpook National University Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Stomach Diseases
- Pathological Conditions, Anatomical
- Adenoma
- Stomach Neoplasms
- Polyps
- Adenomatous Polyps
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Anti-Bacterial Agents
- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P-450 Enzyme Inhibitors
- Protein Synthesis Inhibitors
- Clarithromycin
Other Study ID Numbers
- KNUMC_15-1045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori Infection
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingHelicobacter Pylori Infection | Helicobacter Pylori EradicationBangladesh
-
Shandong UniversityRecruitingHelicobacter Pylori Infection | Patient Education | Helicobacter Pylori EradicationChina
-
Shandong UniversityCompletedHelicobacter Pylori Infection Helicobacter Pylori Eradication Patient EducationChina
-
Shanghai Jiao Tong University School of MedicineCompletedCure Rate of Helicobacter Pylori InfectionChina
-
Seoul National University Bundang HospitalRecruitingHelicobacter Pylori Infection | Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation | Helicobacter Pylori Associated Gastrointestinal Disease | Helicobacter Pylori Infection, Susceptibility toKorea, Republic of
-
The First Affiliated Hospital of Nanchang UniversityUnknownBacterial Infection Due to Helicobacter Pylori (H. Pylori) | Eradication Therapy of Helicobacter Pylori | Detection of Helicobacter PyloriChina
-
Tanta UniversityNot yet recruitingPersistent Helicobacter Pylori InfectionEgypt
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedHelicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)Helicobacter Pylori Infection | Helicobacter Pylori gyrA Levofloxacin Resistance Mutation | Fecal Drug Resistance Gene Detection | Helicobacter Pylori Infection, Susceptibility toChina
-
Kaohsiung Veterans General Hospital.Kaohsiung Medical University Chung-Ho Memorial HospitalCompletedHelicobacter Pylori InfectionTaiwan
-
National Taiwan University HospitalCompleted
Clinical Trials on H. pylori eradication (Amoxaxillin, Lanston, Clarithromycin)
-
Centro Hospitalar e Universitário de Coimbra, E...University of CoimbraRecruitingImmunology | Gut Microbiota | Helicobacter PyloriPortugal
-
Hamamatsu UniversityUnknownH. Pylori InfectionJapan
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedHelicobacter Pylori Infection | Immune Thrombocytopenic PurpuraBrazil
-
Soonchunhyang University HospitalCompleted
-
Kyungpook National University HospitalCompleted
-
National Taiwan University HospitalUnknownGastroesophageal Reflux DiseaseTaiwan
-
Soonchunhyang University HospitalCompletedH. Pylori InfectionKorea, Republic of
-
Shandong UniversityNot yet recruitingHelicobacter Pylori | the Operative Link on Gastric Intestinal Metaplasia | Operative Link on Gastric Intestinal AssessmentChina
-
Seoul National University HospitalHallym University Medical CenterUnknownImmune Thrombocytopenia | Immune Thrombocytopenic Purpura | Helicobacter PyloriKorea, Republic of
-
Seoul National University Bundang HospitalRecruiting